B2V099 AF NFT

Methylglyoxal synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifmnsawcxlntvw22gjhj5l4wot47aapfke6ujtrye47dnnxpv6c3a/metadata.json
IPFS of structure file: 
bafybeieo7vlk5n6ahcchbmrmonqour6aqwjk6jguxq2jv2rbmldkygvmwa/AF-B2V099-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x8e1Ea8ACD4137C45Bd166cE0e156CFc7ab0b5783
First NFT owner address (bech32): 
genesis13c023tx5zd7yt0gkdnswz4k0c74sk4urrf5dnn
Current NFT ID #233302 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
233302
Accession (UniProt):
B2V099
Name::
Methylglyoxal synthase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V099 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V099|MGSA_CLOBA Methylglyoxal synthase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=mgsA PE=3 SV=1 MRIALIAHDKKKQDIIEFAKRNKETLEKYELLATGTTGKMISEETGLNIKRYLSGPYGGDQQIGGRIAEGTIGLVIFFRDPLTAQPHEPDVSALLRVCDVHNIPVVTNSGTADLIIRQF